U.S. Radiodermatitis Market Size & Outlook, 2023-2030
U.S. radiodermatitis market, 2018-2030 (US$M)
Related Markets
U.S. radiodermatitis market highlights
- The U.S. radiodermatitis market generated a revenue of USD 95.5 million in 2023 and is expected to reach USD 126.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating product in 2023.
- Topical is the most lucrative product segment registering the fastest growth during the forecast period.
Radiodermatitis market data book summary
| Market revenue in 2023 | USD 95.5 million |
| Market revenue in 2030 | USD 126.1 million |
| Growth rate | 4.1% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Dressings |
| Key market players worldwide | Smith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma |
Other key industry trends
- In terms of revenue, U.S. accounted for 23.6% of the global radiodermatitis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. radiodermatitis market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 126.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiodermatitis Market Scope
Radiodermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. radiodermatitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 74.35% in 2023. Horizon Databook has segmented the U.S. radiodermatitis market based on topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the largest market for North America radiodermatitis owing to the presence of high incidence rate of radiation burns induced by radiation therapy in this region. Favorable healthcare reforms by the government such as Obama care Act is expected to widen the consumer base of this market.
Moreover, establishment of non-profit organization such as American Radiation burn Association (ABA), which is dedicated to improve lives of those affected by radiation burns, is expected to fuel the radiodermatitis market.
Market penetration by various major players with advanced products is also a key contributing growth factor of this market. In December 2016, Coloplast A/S acquired Comfort Medical for 160 million USD with a view to provide innovative products and services for advanced radiodermatitis in US market.
Reasons to subscribe to U.S. radiodermatitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. radiodermatitis market databook
-
Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. radiodermatitis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. radiodermatitis market size, by product, 2018-2030 (US$M)
U.S. Radiodermatitis Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
